Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01735994 · ClinicalTrials.gov registry record · NA

Efficacy of the Female Athlete Body Project (FAB)

A NA study of Eating Disorders and Female Athlete Triad, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
481
Enrollment target
1
Study location

NCT01735994: Completed NA study of Eating Disorders and Female Athlete Triad, sponsored by Pennington Biomedical Research Center.

NCT01735994 is a NA study of Eating Disorders and Female Athlete Triad that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 481 participants, above the 309-participant average among 37 other Eating Disorders trials with a reported enrollment target (56% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01735994, a NA study of Eating Disorders and Female Athlete Triad, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
481 participants
Enrollment target
1
Study location

Study Summary

Given the cost of treating eating disorders and the substantial morbidity and mortality associated with these disorders, prevention of eating disorders has considerable public health significance. Female athletes represent an important population for prevention due to their risk for the Female Athlete Triad, which includes inadequate energy intake, irregular or cessation of menses, and osteoporosis. The proposed randomized controlled trial will provide important information regarding the efficacy, acceptability, and feasibility of implementing a brief eating disorder prevention and healthy living program within an existing social system of female athletes.

Primary Outcome

The Eating Disorder Examination Questionnaire (EDE-Q) assesses eating disorder behaviors through a self-report questionnaire. There are four subscales of the EDE-Q--Restraint, Eating Concern, Shape Concern, and Weight Concern--with scores for each ranging from 0-6. Overall scores also range from 0-6. Higher scores reflect greater severity of eating disorder psychopathology. Subscales are averaged to compute a total score.

Interventions

  • BEHAVIORAL Healthy Weight
  • OTHER Brochure

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 481 participants
Start Date 2012-11
Est. Completion 2018-12
Phase NA

What the finished NCT01735994 record still lists

NCT01735994 is an interventional study that assigns participants to a tested intervention. The registered 481 participants enrollment target is mid-sized for trials with a published cap, above the 309-participant average among 37 other Eating Disorders trials with a reported enrollment target (56% higher).

The record links to 2 conditions, with Eating Disorders appearing as the primary indexed condition, and to 2 interventions - of which Healthy Weight is the first listed.

NCT01735994 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT01735994 about?

NCT01735994 is a clinical study titled "Efficacy of the Female Athlete Body Project (FAB)". Given the cost of treating eating disorders and the substantial morbidity and mortality associated with these disorders, prevention of eating disorders has considerable public health significance. Female athletes represent an important population for prevention due to their risk for the Female Athle...

What is the current status of trial NCT01735994?

This trial is currently completed. It is a NA study. The enrollment target is 481 participants. The study started on 2012-11. Estimated completion is 2018-12.

What conditions does trial NCT01735994 study?

This clinical trial studies the following conditions: Eating Disorders, Female Athlete Triad.

What interventions are being tested in trial NCT01735994?

The interventions under investigation include: Healthy Weight (BEHAVIORAL), Brochure (OTHER).

Who is sponsoring clinical trial NCT01735994?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01735994 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Eating Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01735994's enrollment target sits among peer trials

481 4th of 37 higher than 34 of 37 other Eating Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Eating Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04449458 · 482 participants · NA

    The Positively Quit Trial for Smoking Cessation

  • NCT07079631 · 482 participants · Phase 1

    A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

  • NCT01954992 · 480 participants · Phase 3

    Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

  • NCT03023696 · 480 participants · NA

    Can Prophylactic Foraminotomy Prevent C5 Palsy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01735994, the US trial registry maintained by the National Library of Medicine. NCT01735994 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.